Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma

NCT07427953 · clinicaltrials.gov ↗

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma
Drug-Induced Retinopathy

Sponsor

Institute of Oncology Ljubljana